Abstract-When making therapeutic decisions for an individual patient or formulating treatment guidelines on a population level, it is often necessary to utilize information arising from different study designs, settings, or treatments. In clinical practice, heterogeneous information is frequently synthesized qualitatively, whereas in comparative effectiveness research and guideline development, it is imperative that heterogeneous data are integrated quantitatively and in a manner that accurately captures the true uncertainty in the results. Bayesian hierarchical modeling is a technique that utilizes all available information from multiple sources and naturally yields a revised estimate of the treatment effect associated with each source. A hierarchical model consists of multiple levels (ie, a hierarchy) of probability distributions that represent relationships between information arising within single populations or trials, as well as relationships between information arising from different populations or trials. We describe the structure of Bayesian hierarchical models and discuss their advantages over simpler models when multiple information sources are relevant. Key Words: multilevel analysis Ⅲ comparative effectiveness research Ⅲ practice guidelines H ealth care providers must often decide whether to recommend a therapy for a patient for whom directly relevant treatment outcome data are limited or absent. For example, there may be limited experience with the therapy, the disease state may be rare, or the patient may be a member of a population that is underrepresented in available clinical studies. Similarly, those setting health care policy, authoring treatment guidelines, or making coverage determinations must also often make decisions regarding the effectiveness of treatments when directly relevant information is limited. An intuitive approach, frequently used by practicing clinicians, is to consider evidence from related populations and therapies, although the similarity to the patient or population of interest may vary significantly. For example, efficacy data for other drugs in the same class may be available, or the therapy may have been evaluated in populations with different comorbidities, demographic characteristics, or disease severities.Whether at the individual patient or population level, this type of decision-making requires the synthesis of information from heterogeneous sources. Many common statistical methods assume either homogeneity (eg, fixed-effects meta-analysis) or complete independence across populations and are thus ill-suited for the quantitative synthesis of heterogeneous data. Hierarchical, or multilevel, modeling is a statistical method that can be used to quantitatively and coherently combine heterogeneous information. A hierarchical model consists of multiple levels (ie, a hierarchy) of probability distributions that represent relationships between information arising within single populations or trials, as well as relationships between information arising from different popul...